Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apigenin 6-c-glucosyl-7-o-glucoside
1. 20310-89-8
2. Isovitexin-7-o-glucoside
3. Saponaretin-7-o-glucoside
4. Petrocomoside
5. Isovitexin-7-o-beta-d-glucopyranoside
6. Isovitexin 7-o-glucoside
7. Apigenin 6-c-glucosyl-7-o-glucoside
8. 3081z76ox9
9. 4h-1-benzopyran-4-one, 6-.beta.-d-glucopyranosyl-7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-
10. 5-hydroxy-2-(4-hydroxyphenyl)-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
11. Ac1l9b2g
12. Unii-3081z76ox9
13. Saponarin [mi]
14. 7-o-glucosylisovitexin
15. Isovitexin 7-glucoside
16. Schembl2489122
17. Chembl4640510
18. Chebi:75439
19. 7-o-(beta-d-glucosyl)isovitexin
20. Dtxsid10174201
21. Hy-n5083
22. Zinc4097454
23. Mfcd00238679
24. Akos037514829
25. Ccg-208416
26. Apigenin-6-c-glucoside -7-o-glucoside
27. Isovitexin 7-.beta.-d-glucoside
28. 5-hydroxy-2-(4-hydroxyphenyl)-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
29. 6-c-glucosyl-7-o-glucosylapigenin
30. Cs-0032401
31. Isovitexin 7-.beta.-d-glucopyranoside
32. C08064
33. Sr-05000002259
34. Sr-05000002259-2
35. Q63408652
36. (1s)-1,5-anhydro-1-[7-(beta-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-6-yl]-d-glucitol
37. 4h-1-benzopyran-4-one, 3-((6-o-(6-deoxy-beta-l-mannofuranosyl)-beta-o-galactofuranosyl)oxy)-7-((6-deoxy-beta-l-mannopyranosyl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-
38. 5-hydroxy-2-(4-hydroxyphenyl)-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
39. 5-hydroxy-2-(4-hydroxyphenyl)-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]-7-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
40. 6-.beta.-d-glucopyranosyl-7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
| Molecular Weight | 594.5 g/mol |
|---|---|
| Molecular Formula | C27H30O15 |
| XLogP3 | -1.6 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 6 |
| Exact Mass | 594.15847025 g/mol |
| Monoisotopic Mass | 594.15847025 g/mol |
| Topological Polar Surface Area | 256 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 971 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Saponarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Saponarin, including repackagers and relabelers. The FDA regulates Saponarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Saponarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Saponarin supplier is an individual or a company that provides Saponarin active pharmaceutical ingredient (API) or Saponarin finished formulations upon request. The Saponarin suppliers may include Saponarin API manufacturers, exporters, distributors and traders.
Saponarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Saponarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Saponarin GMP manufacturer or Saponarin GMP API supplier for your needs.
A Saponarin CoA (Certificate of Analysis) is a formal document that attests to Saponarin's compliance with Saponarin specifications and serves as a tool for batch-level quality control.
Saponarin CoA mostly includes findings from lab analyses of a specific batch. For each Saponarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Saponarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Saponarin EP), Saponarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Saponarin USP).
LOOKING FOR A SUPPLIER?
